Can we cure the price problem for new cancer technologies?
Access status:
Open Access
Type
PresentationAuthor/s
Sullivan, RichardAbstract
In this lecture we will explore the evidence for the divergences and deficits, investor policy towards pricing and what determines price (such as power relationships), the conflicted relationship between the research communities, patient organisations, the media, regulatory authorities and pharmaceutical sector, and the data around declining value and affordability. What solutions can and should be imposed at both national and supra-national levels?In this lecture we will explore the evidence for the divergences and deficits, investor policy towards pricing and what determines price (such as power relationships), the conflicted relationship between the research communities, patient organisations, the media, regulatory authorities and pharmaceutical sector, and the data around declining value and affordability. What solutions can and should be imposed at both national and supra-national levels?
See less
See less
Date
2017-10-26Department, Discipline or Centre
Menzies Centre for Health PolicyShare